LCI (Linked Color Imaging) for Adenoma Detection in the Right Colon
1 other identifier
interventional
752
1 country
1
Brief Summary
Although colonoscopy with polypectomy can prevent up to 80% of colorectal cancers, a significant adenoma miss rate still exists, particularly in the right colon. Optimizing the detection of adenomas and sessile serrated lesions in the right colon is crucial to increase the effectiveness of colonoscopy in colorectal cancer prevention. Last generation Fuji videocolonscopes incorporates the Linked Color Imaging (LCI), a recently developed technology that differentiates the red colour spectrum more effectively than White Light imaging thanks to its optimal pre-process composition of light spectrum and advanced signal processing. The increased colour contrast results in more accurate delineation of abnormal inflammatory or neoplastic findings of colonic mucosa. Preliminary data suggest that LCI may be improve the detection of neoplastic lesion of colon. The investigators performe a tandem prospective study to compare the right colon adenoma miss rates of LCI colonoscopy with those of conventional white light colonoscopy. Therefore participants scheduled for colonoscopy for the assessment of symptoms or for colorectal cancer screening/surveillance receive the examination of the right colon twice, in a back to back fashion, with standard white light (WL) and with LCI. Patients are randomly assigned (1:1), via computer-generated randomisation with block size of 20, to which procedure is done first. The endoscopist are masked to group allocation until immediately before the cecum is reached. Examinations are performed with Fuji videocolonscopes series 700 (EC-760R, EC-760ZP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 24, 2017
CompletedFirst Posted
Study publicly available on registry
September 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2017
CompletedSeptember 12, 2017
September 1, 2017
5 months
August 24, 2017
September 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Right colon adenoma miss rate
Number of adenomas identified during the second right coloninspection/ overall number of adenomas identified during the first and the second right colon inspection
One year
Secondary Outcomes (2)
Right colon advanced adenomas (size>1 cm and/or high grade displasia and/or villous component) miss rate
One year
Right colon sessile serrated lesions miss rate
One year
Study Arms (2)
WLI (White light Imaging)
NO INTERVENTIONColonoscope withdrawal was performed in the right colon evaluating the mucosa using standard white light.
LCI (Linked Color Imaging)
ACTIVE COMPARATORColonoscope withdrawal was performed in the right colon evaluating the mucosa using LCI (Linked Color Imaging).
Interventions
Colonoscope withdrawal was performed in the right colon evaluating the mucosa using LCI (Linked color imaging)
Eligibility Criteria
You may qualify if:
- all outpatients referred for colonoscopy
You may not qualify if:
- inadequatete bowel preparation (Boston Bowel Preparation Scale (BBPS) \< 2 in one colonic segment)
- previous colonic resection
- inflammatory bowel disease
- ereditary polyposic syndromes
- patients on antithrombotics precluding polyp recetion
- absence of informed consent
- inpatients or patients undergoing urgent colonscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Valduce Hospitallead
Study Sites (1)
Gastroenterology Unit, Valduce Hospital
Como, 22100, Italy
Related Publications (1)
Paggi S, Mogavero G, Amato A, Rondonotti E, Andrealli A, Imperiali G, Lenoci N, Mandelli G, Terreni N, Conforti FS, Conte D, Spinzi G, Radaelli F. Linked color imaging reduces the miss rate of neoplastic lesions in the right colon: a randomized tandem colonoscopy study. Endoscopy. 2018 Apr;50(4):396-402. doi: 10.1055/a-0580-7405. Epub 2018 Mar 14.
PMID: 29539651DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Endoscopy Unit
Study Record Dates
First Submitted
August 24, 2017
First Posted
September 12, 2017
Study Start
July 1, 2017
Primary Completion
December 1, 2017
Study Completion
December 30, 2017
Last Updated
September 12, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share